Medical Device Plastics Companies

The medical device plastics market is projected to grow from USD 21.93 billion in 2025 to USD 31.82 billion by 2030, at a CAGR of 7.7% during the forecast period. The global medical device plastics market is growing rapidly due to rising healthcare expenditure, expanding medical infrastructure, and the increasing adoption of advanced, lightweight plastic materials in device manufacturing. The shift toward noninvasive and disposable medical devices is fueling demand for precision-molded plastic components. The growing prevalence of chronic diseases and an aging population are further driving the need for diagnostic and therapeutic devices. Technological innovations such as 3D printing, micro-molding, and bio-based polymers are enhancing design flexibility and performance. Regulatory support for safer and sustainable medical materials is accelerating adoption worldwide.

Medical Device Plastics Companies

The major players active in the medical device plastics market are based in North America, Europe, and the Asia Pacific region. Jabil Inc. (US), Phillips Medisize (US), Donatelle Plastics, LLC (US), Spectrum Plastics Group (US), Bemis Manufacturing Company (US), Nolato (Sweden), Trelleborg AB (Sweden), Freudenberg Medical (US), Viant (US), and SMC Ltd. (US) are among a few leading players operating in the medical device plastics market. Significant attention has been dedicated to developing cost-effective manufacturing technology in the market to meet evolving global demands. Key players have implemented various growth strategies to solidify their market position. These strategies encompass deals, mergers and acquisitions, collaborations & partnerships, and investments & expansions, all aimed at enhancing their presence in the medical device plastics market.

To know about the assumptions considered for the study download the pdf brochure

Jabil Inc. (US)

Jabil Inc. is recognized as one of the world’s foremost providers of engineering, manufacturing, and supply chain solutions, offering comprehensive services that span the entire product lifecycle from innovation and design to fabrication, assembly, and delivery. The company’s integrated approach enables its clients to streamline manufacturing operations, enhance supply chain efficiency, reduce inventory and logistics costs, and accelerate time-to-market. Operating through dedicated business units that serve as single points of contact, Jabil combines advanced electronic design and design-for-manufacturability expertise with highly automated, continuous-flow production systems. These business units are supported by cross-functional teams that leverage Jabil’s extensive global network and technical capabilities to deliver optimized solutions across a wide range of industries. With operations in more than 25 countries and over 100 strategically located sites, Jabil’s network of healthcare sites consists of 35 manufacturing sites in 12 countries and more than 40 million square feet of manufacturing space. It employs a global workforce of approximately 135,000 people. The company’s major production facilities are in China, Malaysia, Mexico, and the US. Jabil’s operation segments are structured into three key business segments: Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce. The Regulated Industries segment focuses on automotive and transportation, healthcare and packaging, and renewables and energy infrastructure. Under this segment, the company offers medical device plastic products. Intelligent Infrastructure focuses on artificial intelligence (AI), cloud and data center systems, and networking technologies. In contrast, Connected Living and Digital Commerce prioritize digitalization, automation, and robotics, particularly in warehouse automation solutions. With a strong global presence in North America, South America, Europe, and the Middle East & Africa, Jabil leverages its innovation-driven mindset and commitment to operational excellence to support advanced product development and sustainable manufacturing for leading companies around the world.

Phillips Medisize (US)

Phillips Medisize, a Molex company under Koch Industries, is a global contract development and manufacturing organization (CDMO) specializing in the design, development, and production of drug delivery systems, medical devices, and in vitro diagnostic (IVD) solutions. With over 60 years of innovation and a workforce of more than 6,000 employees, the company operates 30 global facilities across 11 countries, including seven innovation centers strategically located in North America, Europe, and Asia. Phillips-Medisize generates annual revenues exceeding USD 1.6 billion, positioning it among the world’s foremost medical CDMOs. As a privately owned company, Phillips-Medisize benefits from the scale, stability, and long-term investment strategy of Koch Industries, one of the largest privately held corporations globally, with annual revenues surpassing USD 125 billion. This backing enables Phillips-Medisize to focus on sustainable, long-term partnerships rather than short-term profitability, ensuring customers receive consistent quality, flexibility, and collaborative support throughout the product lifecycle. The company’s operations are structured across four primary divisions: Pharmaceutical, MedTech, In Vitro Diagnostics, and Non-Medical. Within these divisions, Phillips-Medisize provides comprehensive services ranging from concept design and prototyping to precision molding, automated assembly, packaging, and full-scale production. Its advanced capabilities in injection molding, micro-molding, metal injection molding (MIM), and electronics integration enable the company to deliver high-performance components and complete systems for complex medical devices.

MEDICAL DEVICE PLASTIC MARKET: MARKET RANKING

The ranking of top companies like Jabil (US), Phillips Medisize (US), SMC Ltd. (US), Bemis Manufacturing Company (US), and Spectrum Plastics Group (US) in the medical device plastic market is based on several key factors that reflect their market position, capabilities, and overall contribution to the industry. The top five players in the medical device plastic market have been identified based on their revenue, market share, product offerings, production capacity, innovation, technological advancements, geographical presence, strategic partnerships, financial performance, and sustainability efforts. These key players continue to lead the medical device plastic market by maintaining a competitive edge and delivering high-quality medical device plastic products to various applications. Other major players operating in the market include Freudenberg Medical (US), Viant (US), Nolato (Sweden), and Trelleborg AB (Sweden), among others.

Related Reports:

Medical Device Plastics Market by Material (Standard Plastics, Engineering Plastics), Source, Manufacturing Process (Extrusion, CNC Machining, Injection Molding), Application (Diagnostics Equipment, Surgical Instruments), & Region – Global Forecast to 2030